48 related articles for article (PubMed ID: 21055550)
1. [Pretreatment molecular biology analysis on small size biopsies].
Antoine M; Poulot V; Colombat M; Fleury J; Lacave R; Cadranel J
Ann Pathol; 2010 Nov; 30(5 Suppl 1):67-72. PubMed ID: 21055550
[No Abstract] [Full Text] [Related]
2. Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation.
Morinaga R; Okamoto I; Furuta K; Kawano Y; Sekijima M; Dote K; Satou T; Nishio K; Fukuoka M; Nakagawa K
Lung Cancer; 2007 Dec; 58(3):411-3. PubMed ID: 17601631
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor (EGFR) double-activating somatic mutations in exons 19 and 21 in Japanese non-small cell lung cancer patients.
Masago K; Fujita S; Kim YH; Ichikawa M; Hatachi Y; Fukuhara A; Nagai H; Irisa K; Mio T; Mishima M
Cancer Genet Cytogenet; 2009 Dec; 195(2):179-82. PubMed ID: 19963121
[No Abstract] [Full Text] [Related]
4. EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer.
Smouse JH; Cibas ES; Jänne PA; Joshi VA; Zou KH; Lindeman NI
Cancer; 2009 Feb; 117(1):67-72. PubMed ID: 19347832
[TBL] [Abstract][Full Text] [Related]
5. [Advances in research of molecular imaging of epidermal growth factor receptor in non-small cell lung cancer].
Yu JM; Liu NB
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):81-4. PubMed ID: 19538879
[No Abstract] [Full Text] [Related]
6. Update on epidermal growth factor receptor mutations in non-small cell lung cancer.
Riely GJ; Politi KA; Miller VA; Pao W
Clin Cancer Res; 2006 Dec; 12(24):7232-41. PubMed ID: 17189394
[TBL] [Abstract][Full Text] [Related]
7. Impact of EGFR mutation analysis in non-small cell lung cancer.
Yamamoto H; Toyooka S; Mitsudomi T
Lung Cancer; 2009 Mar; 63(3):315-21. PubMed ID: 18760859
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of chronic obstructive pulmonary disease-related non-small cell lung cancer through aberrant methylation and alterations of EGFR signaling.
Suzuki M; Wada H; Yoshino M; Tian L; Shigematsu H; Suzuki H; Alaa M; Tamura H; Fujiwara T; Nagato K; Motohashi S; Moriya Y; Hoshino H; Yoshida S; Shibuya K; Hiroshima K; Nakatani Y; Yoshino I
Ann Surg Oncol; 2010 Mar; 17(3):878-88. PubMed ID: 19841986
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival.
Brabender J; Danenberg KD; Metzger R; Schneider PM; Park J; Salonga D; Hölscher AH; Danenberg PV
Clin Cancer Res; 2001 Jul; 7(7):1850-5. PubMed ID: 11448895
[TBL] [Abstract][Full Text] [Related]
10. Modern treatment of lung cancer: case 1. Amplification and mutation of the epidermal growth factor receptor in metastatic lung cancer with remission from gefitinib.
Schwab R; Pinter F; Moldavy J; Papay J; Strausz J; Kopper L; Keri G; Pap A; Petak I; Oreskovich K; Mangel L
J Clin Oncol; 2005 Oct; 23(30):7736-8. PubMed ID: 16234532
[No Abstract] [Full Text] [Related]
11. EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.
Marchetti A; Martella C; Felicioni L; Barassi F; Salvatore S; Chella A; Camplese PP; Iarussi T; Mucilli F; Mezzetti A; Cuccurullo F; Sacco R; Buttitta F
J Clin Oncol; 2005 Feb; 23(4):857-65. PubMed ID: 15681531
[TBL] [Abstract][Full Text] [Related]
12. Adequacy and complications of computed tomography-guided core needle biopsy on non-small cell lung cancers for epidermal growth factor receptor mutations demonstration: 18-gauge or 20-gauge biopsy needle.
Cheung YC; Chang JW; Hsieh JJ; Lin G; Tsai YH
Lung Cancer; 2010 Feb; 67(2):166-9. PubMed ID: 19450892
[TBL] [Abstract][Full Text] [Related]
13. Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer.
Kotsakis A; Georgoulias V
Expert Opin Pharmacother; 2010 Oct; 11(14):2363-89. PubMed ID: 20586711
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer--a review of the literature.
Araújo A; Ribeiro R; Azevedo I; Coelho A; Soares M; Sousa B; Pinto D; Lopes C; Medeiros R; Scagliotti GV
Oncologist; 2007 Feb; 12(2):201-10. PubMed ID: 17296816
[TBL] [Abstract][Full Text] [Related]
15. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
Cho WC; Chow AS; Au JS
Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
[TBL] [Abstract][Full Text] [Related]
16. First-line treatment for advanced nonsmall cell lung cancer harboring activating epidermal growth factor receptor mutation: epidermal growth factor receptor tyrosine kinase inhibitors or chemotherapy?
Gridelli C
Curr Opin Oncol; 2011 Mar; 23(2):131-2. PubMed ID: 21307676
[No Abstract] [Full Text] [Related]
17. Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor.
Alvarez JV; Greulich H; Sellers WR; Meyerson M; Frank DA
Cancer Res; 2006 Mar; 66(6):3162-8. PubMed ID: 16540667
[TBL] [Abstract][Full Text] [Related]
18. EGFR genotyping in pleural fluid specimens in NSCLC patients.
Cavalli P; Riboli B; Generali D; Passalacqua R; Bosio G
Lung Cancer; 2006 Nov; 54(2):265-6. PubMed ID: 16919840
[No Abstract] [Full Text] [Related]
19. New techniques. Definitive answers to old questions about the pathology of non-small cell carcinoma of the lung?
Marchevsky AM
Am J Clin Pathol; 1992 Feb; 97(2):163-5. PubMed ID: 1312297
[No Abstract] [Full Text] [Related]
20. Molecular Testing in Non-Small-Cell Lung Cancer: A Call to Action.
Sathiyapalan A; Ellis PM
JCO Oncol Pract; 2024 Jan; 20(1):7-9. PubMed ID: 38033274
[No Abstract] [Full Text] [Related]
[Next] [New Search]
